Hologic Inc (LTS:0J5Q)
$ 78.11 -1.51 (-1.9%) Market Cap: 17.93 Bil Enterprise Value: 18.25 Bil PE Ratio: 23.87 PB Ratio: 3.59 GF Score: 85/100

Hologic Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 03:00PM GMT
Release Date Price: $79.73 (-1.47%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Thanks for joining us on day 1 of our health care conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. I'm delighted to have Hologic join us today. And representing the company are Steve MacMillan, CEO; and Karleen Oberton, CFO. Welcome to you both.

Before we kick off with the Q&A, just a quick safe harbor here. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please do reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So Steve, with that, on the -- let's get right to it. On the last earnings call, you provided a long-term organic revenue growth guide of 5% to 7%. Could you walk us through what you view as the key drivers behind that long-term organic growth? And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot